Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Current Oncology (Toronto, Ont.)
|
October 22, 2021
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database
Heidi A I Grosjean, Samantha Dolter, Daniel E Meyers, et al.
Clinical Lung Cancer
|
February 11, 2023
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade
Vishal Navani, Daniel E Meyers, Yibing Ruan, et al.
The Oncologist
|
April 3, 2023
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Igor Stukalin, Vishal Navani, Mehul Gupta, et al.
Clinical Genitourinary Cancer
|
October 21, 2018
Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies
Nils Kroeger, Haoran Li, Guillermo De Velasco, et al.
Clinical Genitourinary Cancer
|
April 17, 2021
Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study
J Connor Wells, Shaan Dudani, Chun Loo Gan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2021
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials
Chun L Gan, Igor Stukalin, Daniel E Meyers, et al.
European Urology
|
June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
J Connor Wells, Igor Stukalin, Craig Norton, et al.
European Urology Oncology
|
February 11, 2020
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Frede Donskov, Wanling Xie, Anders Overby, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Current Oncology (Toronto, Ont.)
|
October 22, 2021
Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database
Heidi A I Grosjean, Samantha Dolter, Daniel E Meyers, et al.
Clinical Lung Cancer
|
February 11, 2023
Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade
Vishal Navani, Daniel E Meyers, Yibing Ruan, et al.
The Oncologist
|
April 3, 2023
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Igor Stukalin, Vishal Navani, Mehul Gupta, et al.
Clinical Genitourinary Cancer
|
October 21, 2018
Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies
Nils Kroeger, Haoran Li, Guillermo De Velasco, et al.
Clinical Genitourinary Cancer
|
April 17, 2021
Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study
J Connor Wells, Shaan Dudani, Chun Loo Gan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2021
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials
Chun L Gan, Igor Stukalin, Daniel E Meyers, et al.
European Urology
|
June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
J Connor Wells, Igor Stukalin, Craig Norton, et al.
European Urology Oncology
|
February 11, 2020
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Frede Donskov, Wanling Xie, Anders Overby, et al.
Journal for Immunotherapy of Cancer
|
March 3, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif, et al.
Page
of 4